Objectives: The study aimed to investigate the relationship between the spontaneous passage of distal ureteral stones and ureteral jet flow measurement. Methods: The study included 74 patients with acute renal colic between June 2015 and June 2016, and distal ureteral stones of 10 mm or less in a non-contrast CT were comprised in a prospective study. The ureteral jet was measured by Doppler ultrasonography. At the fourth week follow-up, kidney-ureter-bladder radiography was taken and the patients who no longer had a stone were considered to have spontaneously passed it. Results: The average stone size of the patients was 5.6 ± 2.0 mm. After 4 weeks of follow-up, 55 patients (74.3%) had passed the stone spontaneously whereas 19 (25.6%) had not. The patients in the former group were found to have a higher peak flow velocity of ureteral jet on the stone side than those in the latter group. In regression analysis ureteral jet on the stone side was independently associated with spontaneous passage (p = 0.027). For the spontaneous passage, a ureteral jet flow peak velocity above 15.25 cm/s had an 85.4% sensitivity and 63.1% specificity. Conclusions: Measurement of the ureteral jet flow peak velocity can be beneficial in predicting the potential spontaneous passage of distal ureteral stones.

Keywords:
Ureteral stone, Ureteral jets, Spontaneous passage
1.
Trinchieri A, Curhan GC, Karlsen S, Wu KJ: Epidemiology; in Segura JW, KS, Pak CY, Preminger GM, Tolley D (eds): Stone Disease. Paris, Health Publications, 2003, pp 13–30.
2.
Gravas S, Tzortzis V, Karatzas A, Oeconomou A, Melekos MD: The use of tamsulozin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it? Results from a randomised study. Urol Res 2007; 35: 231–235.
3.
Lotan Y, Gettman MT, Roehrborn CG, Cadeddu JA, Pearle MS: Management of ureteral calculi: a cost comparison and decision making analysis. J Urol 2002; 167: 1621–1629.
4.
Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck C, Gallucci M, et al: 2007 guideline for the management of ureteral calculi. J Urol 2007; 178: 2418–2434.
5.
Skolarikos A, Laguna MP, Alivizatos G, Kural AR, de la Rosette JJ: The role for active monitoring in urinary stones: a systematic review. J Endourol 2010; 24: 923–930.
6.
Tuerxun A, Batuer A, Erturhan S, Eryildirim B, Camur E, Sarica K: Impaction and prediction: does ureteral wall thickness affect the success of medical expulsive therapy in pediatric ureteral stones? Urol Int 2017; 98: 436–441.
7.
Ueno A, Kawamura T, Ogawa A, Takayasu H: Relation of spontaneous passage of ureteral calculi to size. Urology 1977; 10: 544–546.
8.
Campschroer T, Zhu Y, Duijvesz D, Grobbee DE, Lock MT: Alpha-blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst Rev 2014; 4:CD008509.
9.
Jandaghi AB, Falahatkar S, Alizadeh A, Kanafi AR, Pourghorban R, Shekarchi B, Zirak AK, Esmaeili S: Assessment of ureterovesical jet dynamics in obstructed ureter by urinary stone with color Doppler and duplex Doppler examinations. Urolithiasis 2013; 41: 159–163.
10.
Ongun S, Teken A, Yılmaz O, Süleyman S: Relationship between ureteral jet flow, visual analogue scale, and ureteral stone size. Urology 2017; 104: 36–39.
11.
Leung VY, Chu WC, Yeung CK, Metreweli C: Doppler waveforms of the ureteric jet: an overview and implications for the presence of a functional sphincter at the vesicoureteric junction. Pediatr Radiol 2007; 37: 417–425.
12.
Leung VY, Metreweli C, Yeung CK: The ureteric jet doppler waveform as an indicator of vesicoureteric sphincter function in adults and children. An observational study. Ultrasound Med Biol 2002; 28: 865–872.
13.
Coll DM, Varanelli MJ, Smith RC: Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol 2002; 178: 101–103.
14.
Hubner WA, Irby P, Stoller ML: Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol 1993; 24: 172–176.
15.
Miller OF, Kane CJ: Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 1999; 162: 688–690; discussion 690–691.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.